CN107632105A - Ornidazole purity rubric material and preparation method and application - Google Patents
Ornidazole purity rubric material and preparation method and application Download PDFInfo
- Publication number
- CN107632105A CN107632105A CN201710777918.0A CN201710777918A CN107632105A CN 107632105 A CN107632105 A CN 107632105A CN 201710777918 A CN201710777918 A CN 201710777918A CN 107632105 A CN107632105 A CN 107632105A
- Authority
- CN
- China
- Prior art keywords
- ornidazole
- purity
- material powder
- definite value
- percentage composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 229960002313 ornidazole Drugs 0.000 title claims abstract description 156
- IPWKIXLWTCNBKN-UHFFFAOYSA-N Madelen Chemical compound CC1=NC=C([N+]([O-])=O)N1CC(O)CCl IPWKIXLWTCNBKN-UHFFFAOYSA-N 0.000 title claims abstract description 155
- 239000000463 material Substances 0.000 title claims abstract description 34
- 238000002360 preparation method Methods 0.000 title claims abstract description 10
- 239000000126 substance Substances 0.000 claims abstract description 62
- 239000012535 impurity Substances 0.000 claims abstract description 45
- 238000000034 method Methods 0.000 claims abstract description 44
- 239000000843 powder Substances 0.000 claims abstract description 42
- 239000002994 raw material Substances 0.000 claims abstract description 24
- 238000010606 normalization Methods 0.000 claims abstract description 19
- 238000005070 sampling Methods 0.000 claims abstract description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 9
- 238000004128 high performance liquid chromatography Methods 0.000 claims abstract description 8
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 54
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 36
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 33
- 238000005481 NMR spectroscopy Methods 0.000 claims description 19
- 239000000243 solution Substances 0.000 claims description 17
- 238000004458 analytical method Methods 0.000 claims description 13
- 239000000203 mixture Substances 0.000 claims description 13
- 239000007864 aqueous solution Substances 0.000 claims description 9
- 238000009616 inductively coupled plasma Methods 0.000 claims description 9
- 238000012360 testing method Methods 0.000 claims description 9
- 229910052748 manganese Inorganic materials 0.000 claims description 8
- 239000010421 standard material Substances 0.000 claims description 7
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 claims description 6
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 claims description 6
- 150000001875 compounds Chemical class 0.000 claims description 6
- 229910052750 molybdenum Inorganic materials 0.000 claims description 5
- 229910052785 arsenic Inorganic materials 0.000 claims description 4
- 229910052791 calcium Inorganic materials 0.000 claims description 4
- 229910052802 copper Inorganic materials 0.000 claims description 4
- 238000011156 evaluation Methods 0.000 claims description 4
- 238000003988 headspace gas chromatography Methods 0.000 claims description 4
- 150000002500 ions Chemical class 0.000 claims description 4
- 229910052742 iron Inorganic materials 0.000 claims description 4
- 229910052745 lead Inorganic materials 0.000 claims description 4
- 229910052749 magnesium Inorganic materials 0.000 claims description 4
- 229910052759 nickel Inorganic materials 0.000 claims description 4
- 229910052698 phosphorus Inorganic materials 0.000 claims description 4
- 229910052700 potassium Inorganic materials 0.000 claims description 4
- 229910052701 rubidium Inorganic materials 0.000 claims description 4
- 229910052708 sodium Inorganic materials 0.000 claims description 4
- 229910052712 strontium Inorganic materials 0.000 claims description 4
- 229910052719 titanium Inorganic materials 0.000 claims description 4
- 229910052725 zinc Inorganic materials 0.000 claims description 4
- 241001465754 Metazoa Species 0.000 claims description 3
- 229910052792 caesium Inorganic materials 0.000 claims description 3
- 239000003814 drug Substances 0.000 claims description 3
- 235000013305 food Nutrition 0.000 claims description 3
- 238000013112 stability test Methods 0.000 claims description 3
- 229910052718 tin Inorganic materials 0.000 claims description 3
- 238000010813 internal standard method Methods 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 claims description 2
- 238000001225 nuclear magnetic resonance method Methods 0.000 claims description 2
- 238000003908 quality control method Methods 0.000 claims description 2
- 230000005311 nuclear magnetism Effects 0.000 claims 2
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims 1
- 238000013459 approach Methods 0.000 claims 1
- 150000003851 azoles Chemical class 0.000 claims 1
- 229910052801 chlorine Inorganic materials 0.000 claims 1
- 239000000460 chlorine Substances 0.000 claims 1
- 241000411851 herbal medicine Species 0.000 claims 1
- FGIUAXJPYTZDNR-UHFFFAOYSA-N potassium nitrate Chemical compound [K+].[O-][N+]([O-])=O FGIUAXJPYTZDNR-UHFFFAOYSA-N 0.000 claims 1
- 239000012925 reference material Substances 0.000 abstract description 13
- 238000001514 detection method Methods 0.000 abstract description 10
- 238000012544 monitoring process Methods 0.000 abstract description 8
- 239000003640 drug residue Substances 0.000 abstract description 4
- 244000144972 livestock Species 0.000 abstract description 3
- 235000013613 poultry product Nutrition 0.000 abstract description 3
- 238000012502 risk assessment Methods 0.000 abstract description 3
- 238000005259 measurement Methods 0.000 description 31
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid group Chemical group C(C1=CC=CC=C1)(=O)O WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 28
- 239000000523 sample Substances 0.000 description 27
- 239000005711 Benzoic acid Substances 0.000 description 14
- 235000010233 benzoic acid Nutrition 0.000 description 14
- 239000003153 chemical reaction reagent Substances 0.000 description 10
- 238000002474 experimental method Methods 0.000 description 10
- 238000010966 qNMR Methods 0.000 description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 9
- 238000004811 liquid chromatography Methods 0.000 description 9
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 8
- 238000001228 spectrum Methods 0.000 description 8
- 239000012086 standard solution Substances 0.000 description 8
- OKKJLVBELUTLKV-MZCSYVLQSA-N Deuterated methanol Chemical compound [2H]OC([2H])([2H])[2H] OKKJLVBELUTLKV-MZCSYVLQSA-N 0.000 description 6
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 6
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- 230000029087 digestion Effects 0.000 description 6
- 239000007788 liquid Substances 0.000 description 6
- 230000007774 longterm Effects 0.000 description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 5
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 5
- 239000007789 gas Substances 0.000 description 5
- 239000001257 hydrogen Substances 0.000 description 5
- 229910052739 hydrogen Inorganic materials 0.000 description 5
- 229910021642 ultra pure water Inorganic materials 0.000 description 5
- 239000012498 ultrapure water Substances 0.000 description 5
- 238000005303 weighing Methods 0.000 description 5
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 4
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 4
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 238000004993 emission spectroscopy Methods 0.000 description 4
- 238000001095 inductively coupled plasma mass spectrometry Methods 0.000 description 4
- 238000002347 injection Methods 0.000 description 4
- 239000007924 injection Substances 0.000 description 4
- 238000007689 inspection Methods 0.000 description 4
- 238000004255 ion exchange chromatography Methods 0.000 description 4
- 238000000120 microwave digestion Methods 0.000 description 4
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 4
- 229910017604 nitric acid Inorganic materials 0.000 description 4
- 238000004806 packaging method and process Methods 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 238000012546 transfer Methods 0.000 description 4
- 229910052788 barium Inorganic materials 0.000 description 3
- 238000004364 calculation method Methods 0.000 description 3
- -1 dilute to volume Substances 0.000 description 3
- 238000011835 investigation Methods 0.000 description 3
- 238000000425 proton nuclear magnetic resonance spectrum Methods 0.000 description 3
- 238000011002 quantification Methods 0.000 description 3
- 238000004445 quantitative analysis Methods 0.000 description 3
- 230000004044 response Effects 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- HNSDLXPSAYFUHK-UHFFFAOYSA-N 1,4-bis(2-ethylhexyl) sulfosuccinate Chemical compound CCCCC(CC)COC(=O)CC(S(O)(=O)=O)C(=O)OCC(CC)CCCC HNSDLXPSAYFUHK-UHFFFAOYSA-N 0.000 description 2
- 238000005160 1H NMR spectroscopy Methods 0.000 description 2
- 241000287828 Gallus gallus Species 0.000 description 2
- 229910002651 NO3 Inorganic materials 0.000 description 2
- KAESVJOAVNADME-UHFFFAOYSA-N Pyrrole Chemical compound C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 description 2
- 101150067286 STS1 gene Proteins 0.000 description 2
- 239000012491 analyte Substances 0.000 description 2
- 229910052786 argon Inorganic materials 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- MYSWGUAQZAJSOK-UHFFFAOYSA-N ciprofloxacin Chemical compound C12=CC(N3CCNCC3)=C(F)C=C2C(=O)C(C(=O)O)=CN1C1CC1 MYSWGUAQZAJSOK-UHFFFAOYSA-N 0.000 description 2
- 239000000112 cooling gas Substances 0.000 description 2
- 230000001186 cumulative effect Effects 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 230000005284 excitation Effects 0.000 description 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 2
- 238000001208 nuclear magnetic resonance pulse sequence Methods 0.000 description 2
- 238000005457 optimization Methods 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- LPXPTNMVRIOKMN-UHFFFAOYSA-M sodium nitrite Chemical compound [Na+].[O-]N=O LPXPTNMVRIOKMN-UHFFFAOYSA-M 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- WWZKQHOCKIZLMA-UHFFFAOYSA-N Caprylic acid Natural products CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 1
- 238000001159 Fisher's combined probability test Methods 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- MKUXAQIIEYXACX-UHFFFAOYSA-N aciclovir Chemical compound N1C(N)=NC(=O)C2=C1N(COCCO)C=N2 MKUXAQIIEYXACX-UHFFFAOYSA-N 0.000 description 1
- 229960004150 aciclovir Drugs 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- 230000003103 anti-anaerobic effect Effects 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 239000003904 antiprotozoal agent Substances 0.000 description 1
- 229940058965 antiprotozoal agent against amoebiasis and other protozoal diseases nitroimidazole derivative Drugs 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- GONOPSZTUGRENK-UHFFFAOYSA-N benzyl(trichloro)silane Chemical compound Cl[Si](Cl)(Cl)CC1=CC=CC=C1 GONOPSZTUGRENK-UHFFFAOYSA-N 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 239000012159 carrier gas Substances 0.000 description 1
- 210000003850 cellular structure Anatomy 0.000 description 1
- 229960003405 ciprofloxacin Drugs 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000000498 cooling water Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 229960001617 ethyl hydroxybenzoate Drugs 0.000 description 1
- 239000004403 ethyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010228 ethyl p-hydroxybenzoate Nutrition 0.000 description 1
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 description 1
- 238000012854 evaluation process Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 238000007429 general method Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 125000000623 heterocyclic group Chemical group 0.000 description 1
- 238000010829 isocratic elution Methods 0.000 description 1
- 238000004895 liquid chromatography mass spectrometry Methods 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- FUZZWVXGSFPDMH-UHFFFAOYSA-N n-hexanoic acid Natural products CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 1
- 150000004957 nitroimidazoles Chemical class 0.000 description 1
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 1
- 230000009965 odorless effect Effects 0.000 description 1
- 238000001543 one-way ANOVA Methods 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 235000010288 sodium nitrite Nutrition 0.000 description 1
- 230000003595 spectral effect Effects 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 238000004448 titration Methods 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- 238000013076 uncertainty analysis Methods 0.000 description 1
- 238000009827 uniform distribution Methods 0.000 description 1
- 238000010200 validation analysis Methods 0.000 description 1
- 239000000273 veterinary drug Substances 0.000 description 1
- 239000012224 working solution Substances 0.000 description 1
Landscapes
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
Abstract
本发明公开了奥硝唑纯度标准物质及其制备方法与应用。它的制备方法,包括如下步骤:1)对奥硝唑原料粉末取样,采用高效液相色谱面积归一化法测定其含量,得到奥硝唑原料粉末的纯度定值;2)测定奥硝唑原料粉末中水、非挥发性杂质和有机挥发性杂质的质量百分含量,按照公式Ⅰ计算,得到奥硝唑纯度标准物质的纯度定值1,记为PHPLC‑AN;PHPLC‑AN=P0×[100%‑Xw‑Xn‑Xv]公式Ⅰ;3)取奥硝唑原料粉末采用定量核磁法测定其含量,得到奥硝唑纯度标准物质的纯度定值2,记为PNMR;4)计算PHPLC‑AN和PNMR的平均值,即得到奥硝唑纯度标准物质的纯度定值。本发明能作为标准物质用于畜禽产品中药物残留的检测,为国家农产品质量安全风险评估与监测溯源体系的建立提供技术支持与物质保证。The invention discloses a standard substance of ornidazole purity, a preparation method and application thereof. Its preparation method comprises the following steps: 1) sampling ornidazole raw material powder, adopting high performance liquid chromatography area normalization method to measure its content, obtaining the purity value of ornidazole raw material powder; 2) measuring ornidazole The mass percent of water, non-volatile impurities and organic volatile impurities in the raw material powder is calculated according to formula 1 to obtain the purity rating 1 of the ornidazole purity standard substance, which is denoted as P HPLC-AN ; P HPLC-AN = P 0 ×[100%-X w -X n- X v ] formula I; 3) get ornidazole raw material powder and adopt quantitative nuclear magnetic method to measure its content, obtain the purity value 2 of ornidazole purity standard substance, denoted as P NMR ; 4) calculate the average value of P HPLC-AN and P NMR , obtain the purity value of ornidazole purity standard substance. The invention can be used as a reference material for the detection of drug residues in livestock and poultry products, and provides technical support and material guarantee for the establishment of a national agricultural product quality safety risk assessment and monitoring traceability system.
Description
技术领域technical field
本发明涉及奥硝唑纯度标准物质及其制备方法与应用,属于化学计量中标准量值传递技术领域。The invention relates to ornidazole purity standard substance and its preparation method and application, and belongs to the technical field of standard quantity transfer in chemical measurement.
背景技术Background technique
禁限用药物在畜牧养殖过程中滥用情况严重,由于其具有较强的毒副作用和毒性作用,且在动物组织中的残留会通过食物链传给人类,长期微量摄入会引起多种疾病,对人类的健康造成危害。禁限用药物已成为农业部农产品质量安全风险评估与监测活动的重要参数,为保证测量结果的一致性、可比性、可溯源性以及量值的准确可靠,急需配套相应的标准物质。Prohibited and restricted drugs are seriously abused in the process of animal husbandry. Because of their strong toxic side effects and toxic effects, and the residues in animal tissues will be transmitted to humans through the food chain, long-term trace intake can cause various diseases. Hazard to human health. Prohibited and restricted drugs have become an important parameter in the risk assessment and monitoring activities of the agricultural product quality and safety of the Ministry of Agriculture. In order to ensure the consistency, comparability, traceability and accuracy and reliability of the measurement results, corresponding reference materials are urgently needed.
奥硝唑中文别名奥尼达唑,英文名称:Ornidazole,主要用做抗厌氧菌及抗原虫药。CAS:16773-42-5。分子式C7H10ClN3O3。相对分子量219.63,熔点86-90℃,沸点443.2℃。为白色至微黄色粉末,无臭,味苦,在甲醇、乙醇中易溶,在水中略溶。储存条件:2-8℃。为第三代硝基咪唑类衍生物,其发挥抗微生物作用的机理可能是:通过其分子中的硝基,在无氧环境中还原成氨基或通过自由基的形成,与细胞成分相互作用,从而导致微生物死亡。奥硝唑的分子结构式如式1所示。Ornidazole Chinese alias Onidazole, English name: Ornidazole, mainly used as anti-anaerobe and anti-protozoal drug. CAS: 16773-42-5. Molecular formula C 7 H 10 ClN 3 O 3 . The relative molecular weight is 219.63, the melting point is 86-90°C, and the boiling point is 443.2°C. It is white to slightly yellow powder, odorless, bitter in taste, easily soluble in methanol and ethanol, slightly soluble in water. Storage conditions: 2-8°C. It is the third generation of nitroimidazole derivatives. The mechanism of its antimicrobial effect may be: through the nitro group in its molecule, it is reduced to an amino group in an oxygen-free environment or through the formation of free radicals, interacting with cell components, resulting in the death of microorganisms. The molecular structural formula of ornidazole is shown in Formula 1.
发明内容Contents of the invention
本发明的目的是提供奥硝唑纯度标准物质及其制备方法与应用,本发明能作为标准物质用于畜禽产品中药物残留的检测,为国家农产品质量安全风险评估与监测溯源体系的建立提供技术支持与物质保证。The purpose of the present invention is to provide ornidazole purity reference material and its preparation method and application. The present invention can be used as reference material for the detection of drug residues in livestock and poultry products, and provides a basis for the establishment of national agricultural product quality safety risk assessment and monitoring traceability system. Technical support and material guarantee.
本发明提供的奥硝唑纯度标准物质的制备方法,包括如下步骤:The preparation method of ornidazole purity standard substance provided by the invention comprises the following steps:
1)对奥硝唑原料粉末取样,采用高效液相色谱面积归一化法测定所述奥硝唑原料粉末中奥硝唑的质量百分含量,得到所述奥硝唑原料粉末的纯度定值;1) Sampling the ornidazole raw material powder, using the high performance liquid chromatography area normalization method to measure the mass percentage of ornidazole in the ornidazole raw material powder, to obtain the purity value of the ornidazole raw material powder ;
2)测定所述奥硝唑原料粉末中水分质量百分含量、非挥发性杂质质量百分含量和有机挥发性杂质质量百分含量,结合步骤1)中测定的所述奥硝唑原料粉末的纯度定值,按照如下公式Ⅰ计算,得到奥硝唑纯度标准物质的纯度定值1,记为PHPLC-AN;2) Determination of the moisture mass percentage content, non-volatile impurity mass percentage content and organic volatile impurity mass percentage content in the ornidazole raw material powder, combined with the described ornidazole raw material powder measured in step 1) The purity value is calculated according to the following formula I to obtain the purity value 1 of the ornidazole purity standard substance, which is denoted as P HPLC-AN ;
PHPLC-AN=P0×[100%-Xw-Xn-Xv]公式Ⅰ;P HPLC-AN =P 0 ×[100%-X w -X n -X v ] formula Ⅰ;
其中,P0为奥硝唑原料粉末的纯度定值,Xw为水分质量百分含量,Xn为非挥发性杂质质量百分含量,Xv为有机挥发性杂质质量百分含量;Wherein, P 0 is the purity fixed value of ornidazole raw material powder, Xw is the moisture mass percentage content, Xn is the non-volatile impurity mass percentage content, X v is the organic volatile impurity mass percentage content;
3)取所述奥硝唑原料粉末采用定量核磁法,测定所述奥硝唑原料粉末中奥硝唑的质量百分含量,得到奥硝唑纯度标准物质的纯度定值2,记为PNMR;3) Get the ornidazole raw material powder and adopt quantitative NMR method to measure the mass percentage of ornidazole in the ornidazole raw material powder, obtain the purity value 2 of the ornidazole purity standard substance, denoted as P NMR ;
4)计算所述奥硝唑纯度标准物质的纯度定值1和所述奥硝唑纯度标准物质的纯度定值2的平均值,即得到奥硝唑纯度标准物质的纯度定值。4) Calculate the average value of the purity rating 1 of the ornidazole purity standard substance and the purity rating 2 of the ornidazole purity standard substance to obtain the purity rating of the ornidazole purity standard substance.
上述的方法中,步骤1)中还包括对所述奥硝唑原料粉末取样采用JJG 1006-1994《一级标准物质技术规范》的要求采用方差分析法进行均匀性检验的步骤。In the above method, step 1) also includes the step of sampling the ornidazole raw material powder according to the requirements of JJG 1006-1994 "Technical Specifications for Primary Standard Substances" and adopting the variance analysis method for uniformity testing.
上述的方法中,步骤1)中还包括对所述奥硝唑原料粉末取样采用直线拟合法进行稳定性检验的步骤;所述稳定性检验根据JJG1006-1994《一级标准物质技术规范》中的要求进行。In the above-mentioned method, step 1) also includes the step of carrying out a stability test using a straight line fitting method to the ornidazole raw material powder sampling; Ask to proceed.
上述的方法中,所述高效液相色谱面积归一化法的色谱条件如下:In the above-mentioned method, the chromatographic condition of described HPLC area normalization method is as follows:
色谱柱:SB-aq(250mm×4.6mm,5.0μm);流动相:由乙腈和乙酸水溶液组成,乙腈与乙酸水溶液的体积份数比为13:87,乙酸水溶液中的乙酸与水的体积份数比为0.001:100;流速:1.0mL/min;进样量:20μL;UV波长:312nm;Chromatographic column: SB-aq (250mm×4.6mm, 5.0μm); mobile phase: composed of acetonitrile and acetic acid aqueous solution, the volume ratio of acetonitrile and acetic acid aqueous solution is 13:87, the volume of acetic acid and water in acetic acid aqueous solution Number ratio: 0.001:100; flow rate: 1.0mL/min; injection volume: 20μL; UV wavelength: 312nm;
所述奥硝唑原料粉末测定时配制为100~500mg/L的奥硝唑甲醇溶液。The ornidazole raw material powder is prepared as a 100-500 mg/L ornidazole methanol solution during measurement.
本发明中,HPLC:岛津LC-20A系统。In the present invention, HPLC: Shimadzu LC-20A system.
上述的方法中,所述定量核磁法采用内标法,所述奥硝唑纯度标准物质的纯度定值2按照如下公式Ⅱ进行计算:In the above-mentioned method, the quantitative NMR method adopts the internal standard method, and the purity rating 2 of the ornidazole purity standard substance is calculated according to the following formula II:
式Ⅱ中:PNMR为采用核磁共振法测得的被测物的纯度;In formula II: P NMR is the purity of the analyte measured by nuclear magnetic resonance;
Ix为所述奥硝唑原料粉末指定峰的积分面积;I x is the integrated area of the designated peak of the ornidazole raw material powder;
Istd为内标物指定峰的积分面积;I std is the integrated area of the specified peak of the internal standard;
nstd为内标物指定峰的核群核个数;n std is the number of nuclei group nuclei of the specified peak of the internal standard;
nx为所述奥硝唑原料粉末指定峰的核群核个数;n x is the number of nuclei group nuclei of the designated peak of the ornidazole raw material powder;
Mx—所述奥硝唑原料粉末的分子量;M x —the molecular weight of the ornidazole raw material powder;
Mstd—内标物的分子量;M std —the molecular weight of the internal standard;
mstd—添加的内标物的质量;m std — the mass of the added internal standard;
mx—所述奥硝唑原料粉末的称样量;m x —the sample weight of the ornidazole raw material powder;
Pstd—内标物的纯度。P std — the purity of the internal standard.
本发明中,所述内标物为苯甲酸。In the present invention, the internal standard substance is benzoic acid.
上述的方法中,采用卡尔费休法测定所述奥硝唑原料粉末中的水分含量;In above-mentioned method, adopt Karl Fischer method to measure the moisture content in described ornidazole raw material powder;
所述奥硝唑原料粉末中非挥发性杂质质量百分含量采用微波消解-电感耦合等离子体质谱法、微波消解-电感耦合等离子体发射光谱法和离子色谱法测定;所述微波消解-电感耦合等离子体质谱法测定非挥发性杂质中的As、Se、Cd、Mn、Sn、Li、Cr、Cs、Ni、Pb、Sr、Rb、Ti和Ba中至少一种的含量;所述微波消解-电感耦合等离子体发射光谱法测定所述非挥发性杂质中的Cu、Ca、Mg、K、Na、P、Mn、Mo、Zn、Fe和Co中至少一种的含量;所述离子色谱法测定氯离子、硝酸根离子和硫酸根离子的含量;The mass percentage content of non-volatile impurities in the ornidazole raw material powder is determined by microwave digestion-inductively coupled plasma mass spectrometry, microwave digestion-inductively coupled plasma emission spectrometry and ion chromatography; the microwave digestion-inductively coupled Plasma mass spectrometry measures the content of at least one of As, Se, Cd, Mn, Sn, Li, Cr, Cs, Ni, Pb, Sr, Rb, Ti and Ba in the non-volatile impurities; the microwave digestion- Inductively coupled plasma emission spectrometry measures the content of at least one of Cu, Ca, Mg, K, Na, P, Mn, Mo, Zn, Fe and Co in the non-volatile impurities; Chloride ion, nitrate ion and sulfate ion content;
采用顶空气相色谱测定所述奥硝唑原料粉末中所述有机挥发性杂质质量百分含量。The mass percentage content of the organic volatile impurities in the ornidazole raw material powder was determined by headspace gas chromatography.
上述的方法中,步骤2)中还包括对奥硝唑纯度标准物质的定值进行不确定度分析的步骤。In the above-mentioned method, step 2) also includes the step of performing uncertainty analysis on the determination of the ornidazole purity standard substance.
本发明还提供了上述的方法得到的定值的所述奥硝唑纯度标准物质。The present invention also provides the ornidazole purity standard substance with definite value obtained by the above method.
本发明中,所述奥硝唑纯度标准物质的质量百分含量的纯度定值为99.9%。In the present invention, the purity of the mass percent content of the ornidazole purity standard substance is rated at 99.9%.
本发明进一步提供了所述奥硝唑纯度标准物质在如下1)-6)任一项中的应用:The present invention further provides the application of the ornidazole purity standard substance in any one of the following 1)-6):
1)作为标准物质应用于农产品生产流通领域中兽药和/或饲料产品中奥硝唑成分检测;1) Used as a reference material for the detection of ornidazole components in veterinary drugs and/or feed products in the field of agricultural product production and circulation;
2)食品领域中畜禽产品中奥硝唑药物残留检测;2) Detection of ornidazole drug residues in livestock and poultry products in the food field;
3)检测实验室质量控制;3) Testing laboratory quality control;
4)作为标准物质对分析仪器校准;4) Calibrate the analytical instrument as a reference material;
5)分析方法确认评价;5) Validation and evaluation of analytical methods;
6)对给定材料赋值。6) Assign a value to a given material.
本发明具有以下优点:The present invention has the following advantages:
本标准物质候选物通过订购相应的市售标准品,并根据其理化特性减压干燥处理,充分摇匀,经定性与初步分析满足要求后,干燥条件下分装。采用液相色谱-面积归一化法(UV检测器)和定量核磁法两种不同原理的方法对标准物质的纯度进行定值,通过使用满足计量学特性要求的制备方法、测量方法和计量器具,保证标准物质特性量值的溯源性。Candidates for this reference material are prepared by ordering corresponding commercially available standard products, drying them under reduced pressure according to their physical and chemical properties, shaking them well, and subpackaging under dry conditions after qualitative and preliminary analysis meet the requirements. Using liquid chromatography-area normalization method (UV detector) and quantitative nuclear magnetic method to determine the purity of standard substances, by using preparation methods, measurement methods and measuring instruments that meet the requirements of metrology characteristics , to ensure the traceability of the characteristic value of the standard substance.
附图说明Description of drawings
图1为本发明奥硝唑纯度标准物质6个月稳定性监测结果。Fig. 1 is the 6-month stability monitoring result of the ornidazole purity standard substance of the present invention.
图2为本发明阿昔洛韦短期稳定性监测结果,其中图2(a)为20℃条件下短期稳定性结果,图2(b)为40℃条件下短期稳定性结果,图2(c)为60℃条件下短期稳定性结果。Fig. 2 is the short-term stability monitoring result of acyclovir of the present invention, wherein Fig. 2 (a) is the short-term stability result under 20 ℃ of conditions, Fig. 2 (b) is the short-term stability result under 40 ℃ of conditions, Fig. 2 (c ) is the short-term stability result at 60°C.
图3为本发明不同浓度条件下奥硝唑色谱图,其中图3(a)为100mg/L的奥硝唑甲醇溶液的色谱图,图3(b)为500mg/L的奥硝唑甲醇溶液。Fig. 3 is the chromatogram of ornidazole under different concentration conditions of the present invention, wherein Fig. 3 (a) is the chromatogram of the ornidazole methanol solution of 100mg/L, and Fig. 3 (b) is the ornidazole methanol solution of 500mg/L .
图4为本发明甲醇空白与奥硝唑候选物样品的色谱图,其中图4(a)为甲醇空白的色谱图,图4(b)为奥硝唑候选物样品的色谱图。Fig. 4 is the chromatogram of methanol blank and ornidazole candidate sample of the present invention, wherein Fig. 4(a) is the chromatogram of methanol blank, and Fig. 4(b) is the chromatogram of ornidazole candidate sample.
图5为非挥发性杂质含量测,其中图5(a)为氯离子的标准曲线,图5(b)为硝酸根的标准曲线,图5(c)为硫酸根离子的标准曲线。Fig. 5 is the measurement of non-volatile impurity content, and wherein Fig. 5 (a) is the standard curve of chloride ion, Fig. 5 (b) is the standard curve of nitrate, Fig. 5 (c) is the standard curve of sulfate ion.
图6为奥硝唑(2000mg/L)的离子色谱图。Fig. 6 is the ion chromatogram of ornidazole (2000mg/L).
图7为奥硝唑中挥发性杂质含量测定,其中图7(a)为奥硝唑顶空色谱图,图7(b)为空气空白的顶空色谱图,图7(c)为奥硝唑与单标对比的顶空气相色谱图。Fig. 7 is the determination of volatile impurity content in ornidazole, wherein Fig. 7 (a) is the headspace chromatogram of ornidazole, Fig. 7 (b) is the headspace chromatogram of air blank, and Fig. 7 (c) is ornidazole Headspace gas chromatogram of azole compared with single standard.
图8为奥硝唑的定量核磁谱图,其图8(a)为奥硝唑的定量核磁谱图(1H-NMR谱),图8(b)为苯甲酸标准物质的定量核磁谱图(1H-NMR谱),图8(c)为奥硝唑和内标混合后的定量核磁谱图(1H-NMR谱)。Fig. 8 is the quantitative NMR spectrum of ornidazole, and its Fig. 8 (a) is the quantitative nuclear magnetic spectrum ( 1 H-NMR spectrum) of ornidazole, and Fig. 8 (b) is the quantitative nuclear magnetic spectrum of benzoic acid standard substance ( 1 H-NMR spectrum), Figure 8(c) is the quantitative NMR spectrum ( 1 H-NMR spectrum) after ornidazole and internal standard are mixed.
图9为奥硝唑纯度标准物质定值不确定度来源分析及评定流程图。Figure 9 is a flow chart of source analysis and assessment of uncertainty in the determination of ornidazole purity reference materials.
具体实施方式detailed description
下述实施例中所使用的实验方法如无特殊说明,均为常规方法。The experimental methods used in the following examples are conventional methods unless otherwise specified.
下述实施例中所用的材料、试剂等,如无特殊说明,均可从商业途径得到。The materials and reagents used in the following examples can be obtained from commercial sources unless otherwise specified.
下述实施例中,标准物质候选物奥硝唑购于TCI公司,批号为Lot SFHEL,标签纯度为99.9%(HPLC)和99.9%(Nonaqueous Titration),候选物的包装规格为25g。分别定性和纯度初步确认后,采用液相色谱法(紫外检测器,UV)进行标准物质均匀性初步检验,减压干燥后,将充分混合好的奥硝唑候选物分装至5.0mL干净的西林瓶中,每个包装100mg,共436瓶。低温(4℃)、避光储存。In the following examples, the standard substance candidate ornidazole was purchased from TCI Company, the batch number is Lot SFHEL, the label purity is 99.9% (HPLC) and 99.9% (Nonaqueous Titration), and the packaging specification of the candidate is 25g. After the preliminary confirmation of the qualitative and purity respectively, the liquid chromatography (ultraviolet detector, UV) was used to carry out the preliminary inspection of the homogeneity of the standard substance. After drying under reduced pressure, the well-mixed ornidazole candidate was divided into 5.0mL clean In vials, each package is 100mg, 436 bottles in total. Store at low temperature (4°C), away from light.
实施例1、奥硝唑纯度标准物质的定值Embodiment 1, the definite value of ornidazole purity standard substance
本发明奥硝唑纯度标准物质的定值步骤如下:The definite value step of ornidazole purity standard substance of the present invention is as follows:
1、均匀性检验1. Uniformity test
根据JJG 1006-1994《一级标准物质技术规范》的要求,对标准物质进行了均匀性检验。本发明采用方差分析法统计检验奥硝唑纯度标准物质的均匀性,从分装的奥硝唑中随机抽取15个包装,每个包装取平行三次,重量-容量法配制100mg/L甲醇溶液,采用定值时的条件,液相色谱-面积归一化法检验,获得的均匀性数据与统计结果如表1所示。According to the requirements of JJG 1006-1994 "Technical Specifications for Primary Reference Materials", the homogeneity test was carried out for the standard materials. The present invention adopts the variance analysis method to statistically check the uniformity of the ornidazole purity standard substance, randomly extracts 15 packages from the subpackaged ornidazole, each package is taken in parallel three times, and the weight-volume method is used to prepare 100mg/L methanol solution, Using the conditions when the value was fixed, liquid chromatography-area normalization method inspection, the obtained uniformity data and statistical results are shown in Table 1.
表1奥硝唑纯度标准物质均匀性检验结果(%)Table 1 ornidazole purity standard substance homogeneity inspection result (%)
根据表1数据,对均匀性检验的数据进行统计分析,结果对均匀性标准偏差sH计算如下:According to the data in Table 1, the data of the homogeneity test were statistically analyzed, and the results The standard deviation s H for homogeneity is calculated as follows:
2、稳定性考察2. Stability inspection
(1)长期稳定性考察(1) Long-term stability study
根据JJG1006-1994《一级标准物质技术规范》中的要求,标准物质稳定性考察按照先密后疏的原则。本发明从2016年2月开始,采用液相色谱法分别在第0、1、3、6个月进行稳定性考察。每次抽取2个包装,采用重量-容量法配制溶液,每个包装平行测定3次,稳定性检验结果如表2和图1所示。由表2和图1可知,本纯度标准物质在4℃避光保存的条件下,六个月纯度量值稳定。According to the requirements in JJG1006-1994 "Technical Specifications for Primary Standard Substances", the stability of standard substances shall be investigated in accordance with the principle of density first and sparseness later. The present invention began in February 2016, and carried out stability investigations at the 0th, 1st, 3rd, and 6th months by liquid chromatography. Two packages were drawn each time, and the solution was prepared by the gravimetric-volume method, and each package was tested 3 times in parallel. The stability test results are shown in Table 2 and Figure 1. It can be seen from Table 2 and Figure 1 that the purity standard substance is stable for six months under the condition of 4°C dark storage.
表2奥硝唑纯度标准物质长期稳定性监测结果(%)Table 2 ornidazole purity standard substance long-term stability monitoring result (%)
(2)短期稳定性考察(2) Short-term stability investigation
将样品置于20℃、40℃和60℃恒温箱中(模拟运输条件)保存,分别在第1、3、5、7、9天进行稳定性监测,检测方法与长期稳定性监测相同。采用趋势分析进行数据考察,结果如表3和图2所示。由表3和图2结果显示,本标准物质在60℃及以下的运输条件下9天内可保证纯度量值稳定。The samples were stored in incubators at 20°C, 40°C, and 60°C (simulating transportation conditions), and the stability monitoring was carried out on the 1st, 3rd, 5th, 7th, and 9th day respectively. The detection method was the same as the long-term stability monitoring. The trend analysis was used to investigate the data, and the results are shown in Table 3 and Figure 2. The results in Table 3 and Figure 2 show that the standard substance can guarantee a stable purity value within 9 days under the transportation conditions of 60°C and below.
表3奥硝唑纯度标准物质短期稳定性考察结果(%)Table 3 ornidazole purity standard substance short-term stability investigation result (%)
综上所述,环丙沙星标准物质6个月长期稳定性良好,在20℃、40℃、60℃的模拟运输温度、9天的运输时间条件下特性量值稳定。In summary, the ciprofloxacin standard substance has good long-term stability for 6 months, and its characteristic values are stable under the simulated transportation temperature of 20°C, 40°C, and 60°C, and the transportation time of 9 days.
3、标准物质定值3. Determination of standard substances
(1)纯度定值:液相色谱-面积归一化法(1) Purity determination: liquid chromatography-area normalization method
按照“国家一级标准物质技术规范”,奥硝唑标准物质定值采用液相色谱-面积归一化法和核磁定量法两种方法。In accordance with the "National Technical Specifications for Primary Standard Substances", two methods of liquid chromatography-area normalization method and NMR quantitative method are used to determine the value of ornidazole standard substance.
面积归一化法包括采用HPLC-UV法进行奥硝唑主组分含量测定,采用卡尔费休库伦法进行候选物中水分含量测定,采用ICP-MS和离子色谱法进行非挥发性杂质含量测定,采用顶空气相色谱法进行挥发性杂质含量测定。核磁定量法采用苯甲酸为内标,选择合适的共振峰内标定量。对奥硝唑纯度标准物质的不确定度进行了来源分析和系统的评定。The area normalization method includes the determination of the main component content of ornidazole by HPLC-UV method, the determination of moisture content in the candidate by Karl Fischer Coulomb method, and the determination of non-volatile impurity content by ICP-MS and ion chromatography , Determination of volatile impurity content by headspace gas chromatography. The NMR quantitative method uses benzoic acid as the internal standard, and selects the appropriate resonance peak internal standard for quantification. The source analysis and systematic assessment of the uncertainty of ornidazole purity reference materials were carried out.
配制100mg/L和500mg/L的奥硝唑甲醇溶液,在同一色谱条件下分别进样(具体见下述奥硝唑液相色谱定值条件)。如图3所示,通过图3比较发现,高浓度条件下杂质的信噪比提高,并且有更多的杂质响应,而且在甲醇溶液中奥硝唑的最大浓度为500mg/L。因此,选用500mg/L的奥硝唑甲醇溶液做进一步的色谱条件优化。Prepare 100mg/L and 500mg/L ornidazole methanol solutions, and inject samples under the same chromatographic conditions (see the following ornidazole liquid chromatography determination conditions for details). As shown in Figure 3, by comparing Figure 3, it is found that the signal-to-noise ratio of impurities is improved under high concentration conditions, and there are more impurity responses, and the maximum concentration of ornidazole in methanol solution is 500mg/L. Therefore, 500 mg/L ornidazole methanol solution was selected for further optimization of chromatographic conditions.
奥硝唑液相色谱定值条件如下:Ornidazole liquid chromatography determination conditions are as follows:
色谱柱:Agilent ZORBAX SB-aq(250mm×4.6mm,5.0μm);由乙腈和乙酸水溶液组成,乙腈与乙酸水溶液的体积份数比为13:87,乙酸水溶液中的乙酸与水的体积份数比为0.001:100;流速:1.0mL/min;进样量:20μL;UV波长:312nm;HPLC:岛津LC-20A系统。Chromatographic column: Agilent ZORBAX SB-aq (250mm×4.6mm, 5.0μm); composed of acetonitrile and acetic acid aqueous solution, the volume fraction ratio of acetonitrile and acetic acid aqueous solution is 13:87, the volume fraction of acetic acid and water in acetic acid aqueous solution The ratio is 0.001:100; flow rate: 1.0mL/min; injection volume: 20μL; UV wavelength: 312nm; HPLC: Shimadzu LC-20A system.
如图4所示,通过比较甲醇空白与奥硝唑候选物样品的色谱图,以确定主成分与杂质。As shown in Figure 4, the main components and impurities were determined by comparing the chromatograms of the methanol blank and the ornidazole candidate sample.
实验选取7个包装单元,每个包装取样量为25mg,用甲醇配制为50mL溶液,配制浓度为500mg/mL。在优化好的液相色谱条件下测定奥硝唑主成分纯度,测定三次取平均值,结果表4所示。7 packaging units were selected for the experiment, and the sampling volume of each packaging was 25 mg, which was prepared into a 50 mL solution with methanol at a concentration of 500 mg/mL. The purity of the main component of ornidazole was measured under optimized liquid chromatography conditions, and the average value was measured three times. The results are shown in Table 4.
表4奥硝唑主成分面积归一化法含量测定结果(%)Table 4 ornidazole main component area normalization method content determination result (%)
(2)杂质含量的测定(2) Determination of impurity content
1)水分含量测定1) Determination of moisture content
对实验选取的用于定值的7个包装单元采用METTLER TOLEDO DL39串联METTLERTOLEDO Stromboli仪,依国标(GB/T606化学试剂水分测定通用法卡尔-费休法)测定水分,测三次取平均值,结果如表5所示。For the 7 packaging units selected in the experiment for definite value, the METTLER TOLEDO DL39 series METTLERTOLEDO Stromboli instrument was used to measure the moisture according to the national standard (GB/T606 Chemical Reagent Moisture Determination General Method Karl-Fisher method), and the average value was measured three times. The result As shown in Table 5.
表5奥硝唑水分含量测定结果(%)Table 5 ornidazole moisture content measurement result (%)
2)非挥发性杂质含量测定2) Determination of non-volatile impurity content
2)-1电感耦合等离子体质谱法2)-1 Inductively coupled plasma mass spectrometry
本发明采用微波消解-电感耦合等离子体质谱法(Microwave-assisted ICP-MS)检测奥硝唑纯度标准物质中的As,Se,Cd,Mn,Sn,Li,Cr,Cs,Ni,Pb,Sr,Rb,Ti,Ba含量,具体实验过程如下。The present invention uses microwave digestion-inductively coupled plasma mass spectrometry (Microwave-assisted ICP-MS) to detect As, Se, Cd, Mn, Sn, Li, Cr, Cs, Ni, Pb, Sr in ornidazole purity standard substances , Rb, Ti, Ba content, the specific experimental process is as follows.
实验仪器及试剂:Experimental equipment and reagents:
电感耦合等离子体质谱仪(ICP-MS)赛默飞世尔有限公司ICP-MS X series 2,万分之一分析天平,纯度>99.99%高纯氩气,CEM微波消解仪(MARS SYSTEM),超纯水,硝酸(优级纯),双氧水(优级纯),As,Se,Cd,Mn,Mo,Co,Cu,Cs,Ni,Pb,Sr,Rb,Ti,Ba混合标准溶液(10mg/L)。Inductively coupled plasma mass spectrometer (ICP-MS) Thermo Fisher Co., Ltd. ICP-MS X series 2, 1/10,000 analytical balance, purity>99.99% high-purity argon, CEM microwave digestion instrument (MARS SYSTEM), Ultrapure water, nitric acid (excellent grade), hydrogen peroxide (excellent grade), As, Se, Cd, Mn, Mo, Co, Cu, Cs, Ni, Pb, Sr, Rb, Ti, Ba mixed standard solution (10mg /L).
实验方法:experimental method:
标准工作曲线的建立:标准工作曲线的制作通过配置不同浓度的混标溶液(0.01ppm、0.1ppm、1.0ppm、10.0ppm、50.0ppm)。Establishment of the standard working curve: The standard working curve is prepared by configuring different concentrations of mixed standard solutions (0.01ppm, 0.1ppm, 1.0ppm, 10.0ppm, 50.0ppm).
内标液(In 114):以超纯水作介质,配成溶液浓度为1μg/L。Internal standard solution (In 114): use ultrapure water as the medium, and prepare a solution with a concentration of 1 μg/L.
样品前处理:微波消解法。称取均匀干样0.100g,精确至0.0001g,于55mL消解管中,加5mL硝酸,浸泡过夜,加入1mL双氧水,盖上溶样盖,置于高压罐内,再放入微波溶样装置内,设置微波系统消解程序,开始消解试样。消解完全结束后,取出内罐,放置于赶酸仪上,以100℃加热赶酸至溶液剩余1mL,取下冷却至室温,用水转移入10mL容量瓶中,定容,混匀备用。同时做试剂空白。仪器条件:雾化器流量1.02L/min;吹扫次数45次;辅助气流量0.80L/min;冷却气流量13L/min。Sample pretreatment: microwave digestion. Weigh 0.100g of a uniform dry sample, accurate to 0.0001g, add 5mL of nitric acid to a 55mL digestion tube, soak overnight, add 1mL of hydrogen peroxide, cover the sample-dissolving cap, place it in a high-pressure tank, and then put it into a microwave sample-dissolving device , set the digestion program of the microwave system, and start to digest the sample. After the digestion is complete, take out the inner tank, place it on an acid flusher, heat at 100°C to flush out the acid until 1mL of the solution remains, remove it and cool it to room temperature, transfer it to a 10mL volumetric flask with water, dilute to volume, and mix well for later use. At the same time, make a reagent blank. Instrument conditions: atomizer flow rate 1.02L/min; purging times 45 times; auxiliary gas flow rate 0.80L/min; cooling gas flow rate 13L/min.
2)-2电感耦合等离子体发射光谱法2)-2 Inductively Coupled Plasma Emission Spectrometry
本发明采用微波消解-电感耦合等离子体发射光谱法(Microwave-assisted ICP-AES)检测奥硝唑纯度标准物质中的Cu,Ca,Mg,K,Na,P,Mn,Mo,Zn,Fe,Co含量,实验过程如下。The present invention uses microwave digestion-inductively coupled plasma emission spectrometry (Microwave-assisted ICP-AES) to detect Cu, Ca, Mg, K, Na, P, Mn, Mo, Zn, Fe, Co content, the experimental procedure is as follows.
实验仪器及试剂:电感耦合等离子体发射光谱仪(ICP-AES)上海聚光科技仪器公司ICP-5000,万分之一分析天平,纯度>99.99%高纯氩气,空气压缩机,循环冷却水,CEM微波消解仪(MARS SYSTEM),超纯水,硝酸(优级纯),双氧水(优级纯),Cu,Ca,Mg,K,Na,P,Mn,Mo,Zn,Fe,Co标准溶液(100mg/L)Experimental instruments and reagents: Inductively coupled plasma emission spectrometer (ICP-AES) ICP-5000 from Shanghai Concentrating Technology Instrument Co., Ltd., one ten-thousandth analytical balance, high-purity argon gas with a purity of >99.99%, air compressor, circulating cooling water, CEM microwave digestion instrument (MARS SYSTEM), ultrapure water, nitric acid (excellent grade), hydrogen peroxide (excellent grade), Cu, Ca, Mg, K, Na, P, Mn, Mo, Zn, Fe, Co standard solutions (100mg/L)
实验方法:experimental method:
标准工作曲线的建立:标准工作曲线的制作通过配置不同浓度的混标溶液(0.1ppm、1.0ppm、5.0ppm、10.0ppm)。Establishment of the standard working curve: The standard working curve is prepared by configuring different concentrations of mixed standard solutions (0.1ppm, 1.0ppm, 5.0ppm, 10.0ppm).
样品前处理:微波消解法。称取均匀干样0.100g,精确至0.0001g,于55mL消解管中,加5mL硝酸,浸泡过夜,加入1mL双氧水,盖上溶样盖,置于高压罐内,再放入微波溶样装置内,设置微波系统消解程序,开始消解试样。消解完全结束后,取出内罐,放置于赶酸仪上,以100℃加热赶酸至溶液剩余1mL,取下冷却至室温,用水转移入10mL容量瓶中,定容,混匀备用。同时做试剂空白。仪器条件:水平观测方式;冲洗泵速100rpm;RF功率:1150w;分析泵速50rmp;雾化器流量0.6SLM;分析时间25s;辅助气流量1.0SLM;冷却气流量12SLM。Sample pretreatment: microwave digestion. Weigh 0.100g of a uniform dry sample, accurate to 0.0001g, add 5mL of nitric acid to a 55mL digestion tube, soak overnight, add 1mL of hydrogen peroxide, cover the sample-dissolving cap, place it in a high-pressure tank, and then put it into a microwave sample-dissolving device , set the digestion program of the microwave system, and start to digest the sample. After the digestion is complete, take out the inner tank, place it on an acid flusher, heat at 100°C to flush out the acid until 1mL of the solution remains, remove it and cool it to room temperature, transfer it to a 10mL volumetric flask with water, dilute to volume, and mix well for later use. At the same time, make a reagent blank. Instrument conditions: horizontal observation mode; flushing pump speed 100rpm; RF power: 1150w; analysis pump speed 50rmp; atomizer flow rate 0.6SLM; analysis time 25s; auxiliary gas flow rate 1.0SLM; cooling gas flow rate 12SLM.
通过以上两种方法测得的奥硝唑中各个元素的含量见表6所示。The contents of each element in ornidazole measured by the above two methods are shown in Table 6.
表6奥硝唑纯度标准物质中非挥发性无机元素杂质测定结果Non-volatile inorganic element impurity determination results in table 6 ornidazole purity standard substance
2)-3离子色谱法2)-3 ion chromatography
仪器与试剂:Instruments and reagents:
ICS-3000型离子色谱仪(美国Dionex公司),配有EG40淋洗液自动发生器、电导检测器和Chromeleon 6.80色谱工作站;Ionpac AS11-HC型分离柱(250mm×4mm);IonpacAG11-HC型保护柱(50mm×4mm);ASRS-ULTRA阴离子抑制器;OnGuard RP柱(美国Dionex公司),0.45过滤膜(Milipore公司);超纯水系统(Pine-Tree公司);KQ100-DE超声波清洗器(昆山市超声仪器有限公司)。ICS-3000 ion chromatograph (American Dionex company), equipped with EG40 eluent automatic generator, conductivity detector and Chromeleon 6.80 chromatographic workstation; Ionpac AS11-HC separation column (250mm×4mm); IonpacAG11-HC protection Column (50mm×4mm); ASRS-ULTRA anion suppressor; OnGuard RP column (Dionex, USA), 0.45 filter membrane (Milipore); ultrapure water system (Pine-Tree); KQ100-DE ultrasonic cleaner (Kunshan City Ultrasonic Instrument Co., Ltd.).
亚硝酸钠和己酸等其他有机酸盐标准样品为Sigma公司高纯试剂,所用溶液均用电阻率为18.2MΩ·cm超纯水配制,。The standard samples of sodium nitrite and hexanoic acid and other organic acid salts were high-purity reagents from Sigma Company, and the solutions used were all prepared with ultrapure water with a resistivity of 18.2MΩ·cm.
色谱条件:Chromatographic conditions:
色谱柱:IonPac AS11-HC型分离柱(250mm x4mm),IonPac AG11-HC型保护柱(50mm×4mm);流动相:15mM KOH等度淋洗18min;流速:1.0ml/min;抑制器再生模式:外加水电抑制;电导检测器检测;进样量:25μL。以峰面积定量。Chromatographic column: IonPac AS11-HC separation column (250mm x4mm), IonPac AG11-HC guard column (50mm x 4mm); mobile phase: 15mM KOH isocratic elution for 18min; flow rate: 1.0ml/min; suppressor regeneration mode : Additional hydroelectric suppression; conductivity detector detection; injection volume: 25 μL. Quantified by peak area.
实验结果:Experimental results:
配制氯离子、硝酸根离子和硫酸根离子的标准曲线,标准曲线如图5所示,测定数据如表7所示。Prepare the standard curve of chloride ion, nitrate ion and sulfate ion, the standard curve is shown in Figure 5, and the measurement data are shown in Table 7.
表7离子色谱标准溶液配制浓度及测定结果Table 7 Ion Chromatography Standard Solution Preparation Concentration and Measurement Results
奥硝唑(2000mg/L)的离子色谱图如图6所示,积分结果计算得出奥硝唑纯品中氯离子含量为0.00601%,硝酸根离子在检出限以下,硫酸根离子含量为0.000341%。The ion chromatogram of ornidazole (2000mg/L) is as shown in Figure 6, and integral result calculates that chloride ion content is 0.00601% in the pure product of ornidazole, and nitrate ion is below detection limit, and sulfate ion content is 0.000341%.
综上所述,奥硝唑中非挥发性杂质含量共为0.00935%。In summary, the content of non-volatile impurities in ornidazole is 0.00935%.
3)挥发性杂质含量测定3) Determination of volatile impurities content
奥硝唑合成过程中,不可避免会用到有机溶剂。为了验证纯品中是否存在有机溶剂残留,实验采用顶空气相色谱进行奥硝唑纯品中有机挥发性成分的检测。During the synthesis of ornidazole, organic solvents are inevitably used. In order to verify whether there is organic solvent residue in the pure product, headspace gas chromatography was used in the experiment to detect the organic volatile components in the pure product of ornidazole.
主要仪器与试剂:Agilent 6890型气相色谱仪,氢火焰离子化检测器(FID)(美国Agilent公司),Agilent 1888型顶空自动进样仪(美国Agilent公司),10mL顶空瓶美国Agilent公司),甲醇、乙醇、丙醇、异丙醇、乙腈、正己烷、乙酸乙酯、二氯甲烷标准物质(中国计量科学研究院)。Main instruments and reagents: Agilent 6890 gas chromatograph, hydrogen flame ionization detector (FID) (Agilent, USA), Agilent 1888 headspace autosampler (Agilent, USA), 10mL headspace bottle (Agilent, USA) , methanol, ethanol, propanol, isopropanol, acetonitrile, n-hexane, ethyl acetate, dichloromethane standard material (National Institute of Metrology).
仪器工作条件:色谱柱:DB-624(60m×0.25mm,1.40μm);载气流速:氢气40ml/min、空气400ml/min;程序升温条件:初始45℃保持5min,以每分钟7℃的速率升温至120℃,以每分钟15℃的速率升温至230℃,保持15min。进样量:1mL,分流比:不分流。Instrument working conditions: chromatographic column: DB-624 (60m×0.25mm, 1.40μm); carrier gas flow rate: hydrogen 40ml/min, air 400ml/min; temperature programming conditions: initial 45°C for 5min, at a rate of 7°C per minute The temperature was raised to 120°C at a rate of 15°C per minute to 230°C and kept for 15 minutes. Injection volume: 1mL, split ratio: splitless.
加热箱:70℃;环路:90℃;传输线:110℃Heating box: 70°C; Loop: 90°C; Transfer line: 110°C
实验步骤:分别取10μL甲醇、乙醇、丙醇、异丙醇、乙腈、正己烷、乙酸乙酯、二氯甲烷溶液标准物质分别溶于990μL纯水中并准确记录其质量,置于顶空瓶中立即用压盖器封好制备单标,待测定。分别称取50.00mg(精确至0.01mg)奥硝唑于10mL顶空瓶中立即用压盖器封好,待测定。Experimental procedure: Dissolve 10 μL standard substances of methanol, ethanol, propanol, isopropanol, acetonitrile, n-hexane, ethyl acetate, and dichloromethane solutions in 990 μL of pure water and accurately record their masses, and place them in headspace bottles Immediately seal the prepared single standard with a capper and wait for determination. Weigh 50.00mg (accurate to 0.01mg) of ornidazole in 10mL headspace vials and immediately seal them with a capper, pending determination.
在以上的实验条件下进行样品及单标的测定,实验结果如表8和图7所示。The samples and single standards were measured under the above experimental conditions, and the experimental results are shown in Table 8 and Figure 7.
表8单标的质量与含量记录表Table 8 Quality and Content Record Form of Single Standard
根据保留时间以及与单标和空气空白对比得出奥硝唑候选物中含有甲醇、乙腈两种挥发性杂质,通过峰面积与含量之间的关系来确定甲醇、乙腈的含量,结果如下表9所示,检测结果显示:奥硝唑中挥发性杂质为甲醇和乙腈,但是含量很低,对奥硝唑纯度的定值结果影响极小,故可以忽略。According to the retention time and the comparison with the single standard and the air blank, the ornidazole candidate contains two volatile impurities, methanol and acetonitrile, and the content of methanol and acetonitrile is determined by the relationship between the peak area and the content. The results are shown in Table 9. As shown, the test results show that the volatile impurities in ornidazole are methanol and acetonitrile, but the content is very low, which has little influence on the determination result of the purity of ornidazole, so it can be ignored.
表9奥硝唑中挥发性杂质及其含量Volatile impurities and their content in table 9 ornidazole
4)奥硝唑纯度标准物质的定值结果4) Determination result of ornidazole purity standard substance
液相色谱-面积归一化法(High performance liquid chromatography-areanormalization method,HPLC-AN)纯度定值公式如下:The purity determination formula of liquid chromatography-area normalization method (HPLC-AN) is as follows:
PHPLC-AN=P0×[100%-Xw-Xn-Xv]×100%。P HPLC-AN = P 0 ×[100%-X w -X n -X v ] × 100%.
其中,P0为奥硝唑原料粉末的纯度定值,Xw为水分含量,Xn为非挥发性杂质含量,Xv为挥发性杂质含量。Wherein, P 0 is the purity value of ornidazole raw material powder, X w is the water content, X n is the content of non-volatile impurities, and X v is the content of volatile impurities.
对7瓶分装后奥硝唑候选物采用液相色谱-面积归一化法定值结果如表10所示。The liquid chromatography-area normalization method value results of the ornidazole candidates after 7 bottles of subpackage are shown in Table 10.
表10奥硝唑面积归一化法定值结果(%)Table 10 ornidazole area normalization method value result (%)
(2)纯度定值:定量核磁法(2) Purity fixed value: quantitative NMR method
核磁共振仪器:核磁型号:AvanceⅢ400MHz,1H NMR测定参数:激发脉冲角度90°,采样时间3.9846s,扫描宽度:8223.43Hz,弛豫延迟60s,累计采样16次,探头温度293.4K,偏置频率:2464.5137Hz,接收增益64.00,脉冲序列zg30;电子天平:UMX2,瑞士MettlerToledo公司(分度值:0.1μg);氘代试剂:氘代甲醇(美国sigma公司);核磁用内标:苯甲酸(美国NIST标准物质,SRM-350b,质量分数为99.9978%±0.0044%)。NMR instrument: NMR model: AvanceⅢ400MHz, 1H NMR measurement parameters: excitation pulse angle 90°, sampling time 3.9846s, scan width: 8223.43Hz, relaxation delay 60s, cumulative sampling 16 times, probe temperature 293.4K, bias frequency: 2464.5137Hz, receiving gain 64.00, pulse sequence zg30; electronic balance: UMX2, Swiss MettlerToledo company (graduation value: 0.1 μ g); deuterated reagent: deuterated methanol (US sigma company); NMR internal standard: benzoic acid (US NIST standard material, SRM-350b, mass fraction is 99.9978%±0.0044%).
1H-NMR测试条件: 1 H-NMR test conditions:
激发脉冲角度30度,采样时间3.9846s,扫描宽度:8223.43Hz,弛豫延迟60s,累计采样128次,探头温度293.4K,偏置频率:2464.5137Hz,接收增益64.00,脉冲序列zg30。采样前,经过自动调谐和自动匀场,然后手动调谐和匀场,最后自动调节增益。谱宽20.00ppm,图谱中心位于8.0ppm,纵向弛豫为8.5s。采样结束后,用氘代甲醇定标。利用窗函数(exponential multiplication)优化,线宽因子0.1。The excitation pulse angle is 30 degrees, the sampling time is 3.9846s, the sweep width is 8223.43Hz, the relaxation delay is 60s, the cumulative sampling is 128 times, the probe temperature is 293.4K, the bias frequency is 2464.5137Hz, the receiving gain is 64.00, and the pulse sequence is zg30. Before sampling, it goes through automatic tuning and automatic shimming, then manual tuning and shimming, and finally automatically adjusts the gain. The spectral width is 20.00ppm, the center of the spectrum is located at 8.0ppm, and the longitudinal relaxation is 8.5s. After sampling, deuterated methanol was used for calibration. The window function (exponential multiplication) is used for optimization, and the line width factor is 0.1.
样品的制备:取出保存在4℃的奥硝唑样品,放置在室温条件下,使样品的温度上升至室温。使用精确度为0.01mg的电子天平分别准确称量20mg奥硝唑和10mg内标物苯甲酸(内标物)置于同一玻璃小瓶中,然后将其溶解在氘代甲醇(0.75ml)中。用超声波超声15分钟促进其完全溶解,最后将其转移到(5mm/20cm)核磁管中。依照以上步骤,得到相同7个封存在核磁管中的氘代溶液样品,直接用于氢谱的测定。Sample preparation: take out the ornidazole sample stored at 4° C., place it at room temperature, and raise the temperature of the sample to room temperature. An electronic balance with an accuracy of 0.01 mg was used to accurately weigh 20 mg of ornidazole and 10 mg of internal standard benzoic acid (internal standard) into the same glass vial, and then dissolve it in deuterated methanol (0.75 ml). Ultrasound was used for 15 minutes to promote its complete dissolution, and finally it was transferred to a (5mm/20cm) NMR tube. According to the above steps, the same 7 deuterated solution samples sealed in NMR tubes were obtained, which were directly used for the determination of hydrogen spectra.
重复测量:取同一份封存于核磁管中的奥硝唑氘代溶液,在上述条件下连续测定3次。Repeated measurement: take the same deuterated solution of ornidazole sealed in an NMR tube, and measure 3 times continuously under the above conditions.
数据处理:利用美国的数据处理软件ACD Lab将原始谱图经过傅里叶变换,基线校准,自动相位和手动相位调整后,得到谱图。Data processing: use the American data processing software ACD Lab to process the original spectrogram through Fourier transform, baseline calibration, automatic phase and manual phase adjustment to obtain the spectrogram.
定量核磁测定结果:经实验验证,奥硝唑的分子结构适合使用定量核磁法进行纯度定量,根据其特征峰的位置,本实验选择美国NIST标准物质苯甲酸作为内标物。Quantitative NMR measurement results: It has been verified by experiments that the molecular structure of ornidazole is suitable for quantification of purity by quantitative NMR method. According to the position of its characteristic peak, this experiment selects the US NIST standard substance benzoic acid as the internal standard.
由于奥硝唑在低场场区的H在杂环上,与苯甲酸上苯环的H相互之间不会造成干扰,而且低场区的氢非常特征,所以选择低场区位于δ=7.87的CH特征氢其中的一个作为标定,同时选择内标物苯甲酸上苯环的2,6位氢δ=8.01作为标定。这两个化合物的氢在核磁共振谱图中距离很近,在这个小范围内磁场是相当均匀的,所以用它们的累加的积分面积来测定它们的含量。标准物质苯甲酸的定量核磁谱图和奥硝唑(内标为标准物质苯甲酸)的定量核磁谱图如图8所示。Since the H of ornidazole in the low-field area is on the heterocycle, it will not interfere with the H of the benzene ring on the benzoic acid, and the hydrogen in the low-field area is very characteristic, so the low-field area is selected to be located at δ=7.87 One of the CH characteristic hydrogens was used as a calibration, and the 2,6-position hydrogen δ=8.01 of the benzene ring on the internal standard benzoic acid was selected as a calibration. The hydrogens of these two compounds are very close in the nuclear magnetic resonance spectrum, and the magnetic field is quite uniform in this small range, so their accumulated integral areas are used to determine their content. The quantitative nuclear magnetic spectrum of standard substance benzoic acid and the quantitative nuclear magnetic spectrum of ornidazole (internal standard is standard substance benzoic acid) are as shown in Figure 8.
经方法确认,奥硝唑的分子结构适合使用核磁共振法定量,并可采用纯度标准物质苯甲酸作为内标物,纯度计算公式如下:Confirmed by the method, the molecular structure of ornidazole is suitable for quantification by nuclear magnetic resonance method, and the purity standard substance benzoic acid can be used as the internal standard substance, and the purity calculation formula is as follows:
式中:PNMR—采用核磁共振法测得的被测物的纯度;In the formula: P NMR —the purity of the analyte measured by nuclear magnetic resonance;
Ix—样品指定峰的积分面积;I x —integrated area of the specified peak of the sample;
Istd—内标物指定峰的积分面积;I std —integrated area of internal standard specified peak;
nstd—内标物指定峰的核群核个数;n std — the number of nuclei group nuclei of the specified peak of the internal standard;
nx—样品指定峰的核群核个数;n x - the number of nuclei group nuclei of the specified peak of the sample;
Mx—样品的分子量;M x —molecular weight of the sample;
Mstd—内标物的分子量;M std —the molecular weight of the internal standard;
mstd—添加的内标物的质量;m std — the mass of the added internal standard;
mx—样品的称样量;m x - the weighing amount of the sample;
Pstd—内标物的纯度。P std — the purity of the internal standard.
奥硝唑定量核磁法定值结果如表11所示。The quantitative NMR value results of ornidazole are shown in Table 11.
表11奥硝唑定量核磁法(qNMR)定值结果(%)Table 11 ornidazole quantitative nuclear magnetic method (qNMR) fixed value result (%)
纯度定值结果:Purity rating results:
纯度定值的结果取两种不同原理方法测量结果的平均值,结果如下:The results of the purity determination take the average value of the measurement results of two different principle methods, and the results are as follows:
综上所述,奥硝唑纯度标准物质定值结果为99.9%。In summary, the value determination result of ornidazole purity standard substance is 99.9%.
4、不确定度评价4. Uncertainty evaluation
奥硝唑纯度标准物质的不确定度由三部分组成:标准物质的不均匀引入的不确定度;标准物质的不稳定引入的不确定度;标准物质的定值过程引入的不确定度。The uncertainty of the ornidazole purity reference material consists of three parts: the uncertainty introduced by the inhomogeneity of the standard material; the uncertainty introduced by the instability of the standard material; the uncertainty introduced by the process of determining the value of the standard material.
奥硝唑纯度标准物质不确定度来源分析及评定流程如图9所示。The source analysis and evaluation process of ornidazole purity reference material uncertainty is shown in Figure 9.
(1)均匀性引入的不确定度(1) Uncertainty introduced by uniformity
采用单因素方差分析法进行均匀性评估。则均匀性的标准偏差sH可以用公式计算:Homogeneity was assessed by one-way analysis of variance. Then the standard deviation s H of the uniformity can be calculated by the formula:
式中:sH为均匀性标准偏差;为组间方差;为组内方差;n为组内测量次数。In the formula: s H is the standard deviation of uniformity; is the variance between groups; is the variance within the group; n is the number of measurements within the group.
在这种情况下,sH等同于瓶间不均匀性导致的不确定度分量ubb,即为公式ubb=sH=0.0096%In this case, s H is equal to the uncertainty component u bb caused by the inhomogeneity between bottles, that is, the formula u bb =s H =0.0096%
(2)稳定性引入的不确定度(2) Uncertainty introduced by stability
根据表2的数据,有效期为6个月的长期稳定性引入的不确定度ults计算如下:According to the data in Table 2, the uncertainty u lts introduced by the long-term stability with a valid period of 6 months is calculated as follows:
ults=s(b1)·X=0.000894%×6=0.00408%≈0.00537%u lts =s(b 1 )·X=0.000894%×6=0.00408%≈0.00537%
根据表3的数据,短期稳定性引入的不确定度usts计算如下:According to the data in Table 3, the uncertainty u sts introduced by the short-term stability is calculated as follows:
在20℃下:usts1=s(b1)·X=0.00315%×9=0.028%At 20°C: u sts1 =s(b 1 )·X=0.00315%×9=0.028%
在40℃下:usts1=s(b1)·X=0.00278%×9=0.025%At 40°C: u sts1 =s(b 1 )·X=0.00278%×9=0.025%
在60℃下:usts2=s(b1)·X=0.00014%×9=0.001%At 60°C: u sts2 =s(b 1 )·X=0.00014%×9=0.001%
所以:so:
(3)定值引入的不确定度(3) Uncertainty introduced by fixed value
1)面积归一化法引入的不确定度1) Uncertainty introduced by the area normalization method
面积归一化法的不确定度u(PHPLC-AN)计算公式如下:The calculation formula of the uncertainty u(P HPLC-AN ) of the area normalization method is as follows:
其中,u(PHPLC-AN,rel)为面积归一化法的不确定度,urel(P0)为液相色谱法的不确定度,u(Xw)为水分测量的不确定度,u(Xn)为非挥发性杂质测量的不确定度,u(Xv)为挥发性杂质测量的不确定度。Among them, u(P HPLC-AN, rel ) is the uncertainty of area normalization method, u rel (P 0 ) is the uncertainty of liquid chromatography, u(X w ) is the uncertainty of moisture measurement , u(X n ) is the measurement uncertainty of non-volatile impurities, and u(X v ) is the measurement uncertainty of volatile impurities.
1)-1液相色谱的测量不确定度1)-1 Measurement uncertainty of liquid chromatography
液相色谱法定值测量重复性引入的不确定度u1由测量的标准偏差计算,u1=0.021%;The uncertainty u 1 introduced by the repeatability of the liquid chromatography value measurement is calculated from the standard deviation of the measurement, u 1 = 0.021%;
各成分在不同检测波长下响应差异引入的不确定度:The uncertainty introduced by the response difference of each component at different detection wavelengths:
式中,Bimaxλ为在5个检测波长下杂质成分i的最大百分比含量;In the formula, B imaxλ is the maximum percentage content of impurity component i under the five detection wavelengths;
Bi定值λ为定值波长下杂质成分i的百分比含量;B i fixed value λ is the percentage content of impurity component i at the fixed value wavelength;
u2-i为杂质成分i的不确定度分量。u 2-i is the uncertainty component of impurity component i.
各波长的响应与不确定度评定结果,如表8所示。The response and uncertainty evaluation results of each wavelength are shown in Table 8.
1)-2水分引入的不确定度1)-2 Uncertainty of moisture introduction
天平称样引入的不确定度分量很小,所以水分测量的主要不确定来源是测量的重复性uA,水分的测量结果Xw为0.0131%,标准偏差为0.001%,因此水分测定引入的不确定度:u(XW)=0.001%。The uncertainty component introduced by the balance sample is very small, so the main source of uncertainty in the moisture measurement is the repeatability u A of the measurement, the measurement result X w of the moisture is 0.0131%, and the standard deviation is 0.001%, so the uncertainty introduced by the moisture measurement is not Degree of certainty: u(X W )=0.001%.
1)-3其他杂质引入的不确定度1)-3 Uncertainty introduced by other impurities
天平称样引入的不确定度分量很小,所以非挥发性杂质测量的主要不确定来源是测量的重复性uA,非挥发性杂质的测量结果Xn为0.00935%,因此,认为非挥发性杂质测定的不确定度:u(Xn)=0.00935%。The uncertainty component introduced by the balance sample is very small, so the main source of uncertainty in the measurement of non-volatile impurities is the repeatability u A of the measurement, and the measurement result X n of non-volatile impurities is 0.00935%. Therefore, it is considered that the non-volatile impurities Uncertainty of impurity determination: u(X n )=0.00935%.
1)-4面积归一化法的相对不确定度:1)-4 Relative uncertainty of area normalization method:
1)-5面积归一化法的绝对不确定度:1) Absolute uncertainty of -5 area normalization method:
uHPLC-AN=99.93%×uHPLC-AN,rel=0.027%u HPLC-AN = 99.93% × u HPLC-AN, rel = 0.027%
2)定量核磁法引入的不确定度2) Uncertainty introduced by quantitative NMR method
由核磁定量的公式得出纯度测量不确定度公式:The purity measurement uncertainty formula is obtained from the NMR quantitative formula:
核磁定量法不确定度的来源包括测量的不确定度、分子量不确定度、称量不确定度、内标物纯度不确定度。The sources of NMR quantitative uncertainty include measurement uncertainty, molecular weight uncertainty, weighing uncertainty, and internal standard purity uncertainty.
积分面积测量的不确定度u(Ix/Istd):积分面积测定结果的标准不确定度采用A类评定,用NMR法测定结果的标准偏差表示,不确定度为0.072%。Uncertainty u(I x /I std ) of the integral area measurement: the standard uncertainty of the integral area measurement results is evaluated by Class A, expressed by the standard deviation of the NMR method measurement results, and the uncertainty is 0.072%.
内标物标准物质尼泊金乙酯和样品天平秤量不确定度u(mstd)和u(mx):称量天平的最小分度为0.01mg,称样量为20mg和10mg,所以天秤称量的不确定度为:Internal standard substance ethyl paraben and sample balance uncertainty u(m std ) and u(m x ): the minimum division of the weighing balance is 0.01mg, and the weighing sample size is 20mg and 10mg, so the balance The weighing uncertainty is:
内标物纯度不确定度u(Pstd):内标物苯甲酸的纯度不确定度由标准物质证书获得,纯度值的相对扩展不确定度为0.0044%(k=2),所以其相对标准不确定度为0.0022%。Internal standard purity uncertainty u(P std ): The purity uncertainty of internal standard benzoic acid is obtained from the standard substance certificate, and the relative expanded uncertainty of the purity value is 0.0044% (k=2), so its relative standard The uncertainty is 0.0022%.
分子量的不确定度u(Mx)和u(Mstd):奥硝唑和内标物苯甲酸相对分子量的标准不确定度计算公式:Uncertainty of molecular weight u(M x ) and u(M std ): Calculation formula of standard uncertainty of relative molecular weight of ornidazole and internal standard benzoic acid:
式中:Nj—j元素的原子个数;uj—j元素的相对原子质量的不确定度。In the formula: N j —atomic number of element j; u j —uncertainty of relative atomic mass of element j.
根据IUPAC国际原子量表,4种原子的相对原子质量及不确定度为C:12.0107±0.0008;H:1.00794±0.00007;O:15.9994±0.0003;N:14.00674±0.00007;Cl:35.4527±0.0009。According to the IUPAC International Atomic Scale, the relative atomic masses and uncertainties of the four atoms are C: 12.0107±0.0008; H: 1.00794±0.00007; O: 15.9994±0.0003; N: 14.00674±0.00007; Cl: 35.4527±0.0009.
对于每个元素,其标准不确定度是按照均匀分布由引用不确定度转化而来。For each element, its standard uncertainty is converted from the reference uncertainty according to the uniform distribution.
奥硝唑的分子式为C7H10ClN3O3,相对分子量219.63,其标准不确定度为:The molecular formula of ornidazole is C 7 H 10 ClN 3 O 3 , the relative molecular weight is 219.63, and its standard uncertainty is:
奥硝唑相对分子质量的相对标准不确定度:The relative standard uncertainty of the relative molecular mass of ornidazole:
u(Mx)/Mx=0.0033/219.63=1.5×10-5 u(M x )/M x =0.0033/219.63=1.5×10 −5
同理,内标物苯甲酸(C7H6O2),相对分子量为122.12,其相对标准不确定度:Similarly, the internal standard benzoic acid (C 7 H 6 O 2 ), with a relative molecular weight of 122.12, has a relative standard uncertainty of:
u(Mstd)/Mstd=2.7×10-5。u(M std )/M std =2.7×10 -5 .
因此核磁定量法纯度测量的合成标准不确定度为:Therefore, the synthetic standard uncertainty of NMR quantitative method purity measurement is:
因此,定值不确定度计算如下:Therefore, the fixed value uncertainty is calculated as follows:
标准物质的不确定度:奥硝唑标准物质定值结果的不确定度由定值方法、标准物质的不均匀性及不稳定性带来的不确定度三部分组成。标准物质的总体不确定度计算公式如下:Uncertainty of standard substance: The uncertainty of the value determination result of ornidazole standard substance is composed of three parts: the uncertainty caused by the method of determination, the inhomogeneity of the standard substance and the instability. The formula for calculating the overall uncertainty of the reference material is as follows:
扩展不确定度为:UCRM=k×uCRM=0.4%(k=2)。The expanded uncertainty is: U CRM =k×u CRM =0.4% (k=2).
综上所述,奥硝唑纯度标准物质的量值和不确定度如表12所示。In summary, the values and uncertainties of ornidazole purity standard substances are shown in Table 12.
表12奥硝唑纯度标准物质的纯度、不确定度Purity, uncertainty of table 12 ornidazole purity standard substance
对于出口的鸡肉中药物残留量测定,采用国标方法进行出口鸡肉中奥硝唑检测外,还需要采用奥硝唑标准物质,具体操作为:采用已知纯度的奥硝唑纯度标准物质,采用重量容量法配制标准溶液,绘制工作曲线,同时,将经过样品处理后得到的待测样品与标准工作溶液一起通过液相色谱或者液相色谱质谱检测,通过峰面积计算待测样品中奥硝唑含量,这样能待分析样品中含量就通过本纯度标准物质直接溯源到SI单位,增加了数据的准确性、可比性和可溯源性。For the determination of drug residues in exported chicken, in addition to the national standard method for the detection of ornidazole in exported chicken, it is also necessary to use ornidazole standard substances. Prepare the standard solution by the volumetric method and draw the working curve. At the same time, the sample to be tested and the standard working solution obtained after sample processing are detected by liquid chromatography or liquid chromatography mass spectrometry, and the content of ornidazole in the sample to be tested is calculated by the peak area. , so that the content in the sample to be analyzed can be directly traced to the SI unit through this purity standard substance, which increases the accuracy, comparability and traceability of the data.
Claims (10)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710777918.0A CN107632105A (en) | 2017-08-31 | 2017-08-31 | Ornidazole purity rubric material and preparation method and application |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710777918.0A CN107632105A (en) | 2017-08-31 | 2017-08-31 | Ornidazole purity rubric material and preparation method and application |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN107632105A true CN107632105A (en) | 2018-01-26 |
Family
ID=61099774
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201710777918.0A Pending CN107632105A (en) | 2017-08-31 | 2017-08-31 | Ornidazole purity rubric material and preparation method and application |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN107632105A (en) |
Cited By (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108535069A (en) * | 2018-04-20 | 2018-09-14 | 中国农业科学院农业质量标准与检测技术研究所 | A kind of nobiletin purity rubric substance and the preparation method and application thereof |
| CN110487612A (en) * | 2019-09-12 | 2019-11-22 | 上海诗丹德标准技术服务有限公司 | A kind of schizandrin A purity rubric substance and the preparation method and application thereof |
| CN112067640A (en) * | 2020-08-24 | 2020-12-11 | 西安近代化学研究所 | Method for determining crystal form purity value of HNIW crystal form standard substance |
| CN112067642A (en) * | 2020-08-24 | 2020-12-11 | 西安近代化学研究所 | Method for determining crystal form purity of beta-HMX crystal form standard substance |
| CN112067641A (en) * | 2020-08-24 | 2020-12-11 | 西安近代化学研究所 | Method for determining crystal form purity of alpha-HMX crystal form standard substance |
| CN112098623A (en) * | 2020-08-24 | 2020-12-18 | 西安近代化学研究所 | Method for determining crystal form purity value of alpha-HNIW crystal form standard substance |
| CN112098444A (en) * | 2020-08-24 | 2020-12-18 | 西安近代化学研究所 | Gamma-HNIW crystal form standard substance crystal form purity value determination method |
| CN112816283A (en) * | 2020-12-30 | 2021-05-18 | 国家烟草质量监督检验中心 | Preparation method of tobacco specific N-nitrosamine standard substance |
| CN114353444A (en) * | 2022-01-14 | 2022-04-15 | 成都市海通药业有限公司 | Method for reducing impurity B in ornidazole injection |
| CN116242674A (en) * | 2022-12-29 | 2023-06-09 | 广电计量检测集团股份有限公司 | A kind of rimantadine solution standard substance and its preparation method and application |
Citations (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003027274A2 (en) * | 2001-09-25 | 2003-04-03 | Affinium Pharmaceuticals, Inc. | Purified polypeptides from pseudomonas aeruginosa |
| US20110082179A1 (en) * | 2008-02-02 | 2011-04-07 | Meidong Yang | Methods and compositions for increasing solubility of azole drug compounds that are poorly soluble in water |
| CN102445512A (en) * | 2010-10-09 | 2012-05-09 | 中国人民解放军第二军医大学 | Small molecule metabolite map for identifying liver cancer, hepatitis or liver cirrhosis and preparation method thereof |
| CN102539597A (en) * | 2011-05-24 | 2012-07-04 | 四川省中医药科学院 | Method for quickly identifying notopterygium incisum seed and notopterygium franchetii seed |
| CN102565271A (en) * | 2012-01-10 | 2012-07-11 | 扬子江药业集团南京海陵药业有限公司 | Quality control method for ornidazole |
| CN102818867A (en) * | 2012-08-17 | 2012-12-12 | 吉林敖东药业集团延吉股份有限公司 | Quality control method for ribonucleic acid II for injection |
| CN103389347A (en) * | 2013-07-26 | 2013-11-13 | 深圳市海滨制药有限公司 | Method for measuring Doripenem and/or relevant substances by utilizing high performance liquid chromatography |
| CN103675137A (en) * | 2013-12-12 | 2014-03-26 | 山东齐都药业有限公司 | Ornidazole injection liquid quality control method |
| CN106872233A (en) * | 2017-02-27 | 2017-06-20 | 暨南大学 | A kind of 5 hydroxymethylfurfural cysteine adducts and preparation method and application and detection method |
-
2017
- 2017-08-31 CN CN201710777918.0A patent/CN107632105A/en active Pending
Patent Citations (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003027274A2 (en) * | 2001-09-25 | 2003-04-03 | Affinium Pharmaceuticals, Inc. | Purified polypeptides from pseudomonas aeruginosa |
| US20110082179A1 (en) * | 2008-02-02 | 2011-04-07 | Meidong Yang | Methods and compositions for increasing solubility of azole drug compounds that are poorly soluble in water |
| CN102445512A (en) * | 2010-10-09 | 2012-05-09 | 中国人民解放军第二军医大学 | Small molecule metabolite map for identifying liver cancer, hepatitis or liver cirrhosis and preparation method thereof |
| CN102539597A (en) * | 2011-05-24 | 2012-07-04 | 四川省中医药科学院 | Method for quickly identifying notopterygium incisum seed and notopterygium franchetii seed |
| CN102565271A (en) * | 2012-01-10 | 2012-07-11 | 扬子江药业集团南京海陵药业有限公司 | Quality control method for ornidazole |
| CN102818867A (en) * | 2012-08-17 | 2012-12-12 | 吉林敖东药业集团延吉股份有限公司 | Quality control method for ribonucleic acid II for injection |
| CN103389347A (en) * | 2013-07-26 | 2013-11-13 | 深圳市海滨制药有限公司 | Method for measuring Doripenem and/or relevant substances by utilizing high performance liquid chromatography |
| CN103675137A (en) * | 2013-12-12 | 2014-03-26 | 山东齐都药业有限公司 | Ornidazole injection liquid quality control method |
| CN106872233A (en) * | 2017-02-27 | 2017-06-20 | 暨南大学 | A kind of 5 hydroxymethylfurfural cysteine adducts and preparation method and application and detection method |
Non-Patent Citations (5)
| Title |
|---|
| 国家质检总局进出口食品安全局 等: "《出口禽肉质量控制与安全管理》", 31 October 2011, 中国农业科学技术出版社 * |
| 国家质量监督检验检疫总局: "中华人民共和国标准物质目录", 《HTTP://NACCRM.CHINA-CSM.ORG/NEWS_INFO.ASPX?ID=644》 * |
| 姜瑞玲 等: "HPLC法测定奥硝唑片中有关物质的含量", 《齐鲁药事》 * |
| 宋印清 等: "甲硝唑标准物质的纯度定值分析与不确定度评估研究", 《化学试剂》 * |
| 陈法贵 等: "奥硝唑有关物质分析方法的建立", 《药物分析杂志》 * |
Cited By (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108535069A (en) * | 2018-04-20 | 2018-09-14 | 中国农业科学院农业质量标准与检测技术研究所 | A kind of nobiletin purity rubric substance and the preparation method and application thereof |
| CN110487612A (en) * | 2019-09-12 | 2019-11-22 | 上海诗丹德标准技术服务有限公司 | A kind of schizandrin A purity rubric substance and the preparation method and application thereof |
| CN112098444A (en) * | 2020-08-24 | 2020-12-18 | 西安近代化学研究所 | Gamma-HNIW crystal form standard substance crystal form purity value determination method |
| CN112067642A (en) * | 2020-08-24 | 2020-12-11 | 西安近代化学研究所 | Method for determining crystal form purity of beta-HMX crystal form standard substance |
| CN112067641A (en) * | 2020-08-24 | 2020-12-11 | 西安近代化学研究所 | Method for determining crystal form purity of alpha-HMX crystal form standard substance |
| CN112098623A (en) * | 2020-08-24 | 2020-12-18 | 西安近代化学研究所 | Method for determining crystal form purity value of alpha-HNIW crystal form standard substance |
| CN112067640A (en) * | 2020-08-24 | 2020-12-11 | 西安近代化学研究所 | Method for determining crystal form purity value of HNIW crystal form standard substance |
| CN112067642B (en) * | 2020-08-24 | 2022-10-25 | 西安近代化学研究所 | Method for determining crystal form purity of beta-HMX crystal form standard substance |
| CN112067641B (en) * | 2020-08-24 | 2022-10-25 | 西安近代化学研究所 | Method for determining crystal form purity of alpha-HMX crystal form standard substance |
| CN112098623B (en) * | 2020-08-24 | 2022-10-25 | 西安近代化学研究所 | Method for determining crystal form purity value of alpha-HNIW crystal form standard substance |
| CN112067640B (en) * | 2020-08-24 | 2022-10-25 | 西安近代化学研究所 | Crystal form purity value-defining method for epsilon-HNIW crystal form standard substance |
| CN112816283A (en) * | 2020-12-30 | 2021-05-18 | 国家烟草质量监督检验中心 | Preparation method of tobacco specific N-nitrosamine standard substance |
| CN114353444A (en) * | 2022-01-14 | 2022-04-15 | 成都市海通药业有限公司 | Method for reducing impurity B in ornidazole injection |
| CN114353444B (en) * | 2022-01-14 | 2023-01-03 | 成都市海通药业有限公司 | Method for reducing impurity B in ornidazole injection |
| CN116242674A (en) * | 2022-12-29 | 2023-06-09 | 广电计量检测集团股份有限公司 | A kind of rimantadine solution standard substance and its preparation method and application |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN107632105A (en) | Ornidazole purity rubric material and preparation method and application | |
| CN107607571A (en) | Dimetridazole purity rubric material and preparation method and application | |
| CN106324123B (en) | The measuring method of persticide residue in tobacco and tobacco product | |
| CN105738492B (en) | The method of impurity content in LC MS/MS combination measure Lapatinibs | |
| CN110487612A (en) | A kind of schizandrin A purity rubric substance and the preparation method and application thereof | |
| CN102692390A (en) | Determination method of arsenic content in hot melt glue | |
| CN108827998A (en) | A method of volatile substances purity is accurately measured using quantitative nuclear magnetic resonance spectroscopy | |
| CN105842379A (en) | Method for measuring phenolic estrogen by means of derivation | |
| CN107632076A (en) | The quick instrument analytical method of azanol residual quantity in a kind of reaction solution | |
| CN107687966A (en) | Moroxydine Hydrochloride purity rubric material and preparation method and application | |
| WO2023124923A1 (en) | Method for determining salt forming rate in raw material, i.e., methylergonovine maleate | |
| CN107505348A (en) | Application of the metronidazole as internal standard compound in hydrogen nuclear magnetic resonance technology | |
| CN109212048A (en) | The detection method of impurity content in a kind of voriconazole | |
| CN105510504B (en) | Method for measuring imidazole, musk xylene and sesamol residue quantity in edible essence | |
| CN107543884A (en) | ACV purity rubric material and preparation method and application | |
| CN109633055B (en) | Method for measuring multi-component content of bactericidal and antipruritic lotion | |
| CN109507339A (en) | Measuring method of the liquid chromatogram-high resolution mass spectrometry for crystal methamphetamine in human urine | |
| CN116242674A (en) | A kind of rimantadine solution standard substance and its preparation method and application | |
| Yang et al. | Establishment of metrological traceability for fluoroquinolones measurement in monitoring plan of quality and safety for agro-product in China | |
| Chen et al. | Development of pure certified reference material of squalene | |
| CN108535069A (en) | A kind of nobiletin purity rubric substance and the preparation method and application thereof | |
| CN107300564A (en) | Application of the Dimetridazole as internal standard compound in hydrogen nuclear magnetic resonance technology | |
| CN114354789A (en) | Method for simultaneously determining cabozantinib analogue and related substances thereof | |
| RU2779425C1 (en) | Method for measuring the mass concentrations of aluminum, arsenic, strontium, cadmium, lead, mercury in flour, cereals and bakery products by inductively coupled plasma mass spectrometry | |
| CN109738556A (en) | A kind of preparation method of nicotine standard substance and its nicotine standard substance of preparation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20180126 |
|
| RJ01 | Rejection of invention patent application after publication |